• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Ventas Could Make a Low Now but a Base Pattern Will Need Considerable Work

The charts of VTR have been hurt.
By BRUCE KAMICH
Mar 24, 2020 | 08:46 AM EDT
Stocks quotes in this article: VTR

For his second "Executive Decision" segment of Mad Money Monday night, Jim Cramer sat down with Debra Cafaro, chairman and CEO of Ventas (VTR) , the medical REIT that has plummeted 60% so far this year. Shares of Ventas now yield nearly 14%.

Cafaro said that 2020 started off strong for Ventas, but since the coronavirus pandemic began there has been a lot of fear in the markets and stresses throughout the healthcare system. She reassured investors that Ventas is on a strong financial footing and that's why the company proceeded with its planned dividend.

When asked about the health of their residents, Cafaro said that all precautions are being taken at their facilities.

Let's check out the charts of VTR to see if they are being taken care of as well.

In this daily bar chart of VTR, below, we can see that prices began to weaken back in October, well before the issues with the coronavirus. Prices made a minor low in December and crawled slightly higher into February. Since late February prices plunged from near $65 to around $15. Trading volume soared the past two months telling us that investors voted with their feet and quickly and aggressively sold stock.

The On-Balance-Volume (OBV) line made a new low for the move down telling us that sellers of VTR have been more aggressive. The 12-day price momentum study in the lower panel of the chart shows that the decline is starting to slow but we do not have a bullish divergence that would give us more confidence in that observation.

In this weekly Japanese candlestick chart of VTR, below, we can see what might become a harami pattern (futures traders might call it an inside week). This potential reversal pattern is in the right location and so far the right pattern. We would still need confirmation with a bullish pattern or bar next week. Something to look forward to.

The 40-week moving average line is bearish. The weekly OBV line is bearish and the 12-week momentum study is just starting to slow.

In this first Point and Figure chart of VTR, below, we used daily price data and a traditional plotting. A downside price target of $36 was reached and exceeded.

In this second Point and Figure chart of VTR, below, we used weekly close only data and a traditional plotting. The volume by price data (left scale) suggests that prices should find support (buying interest) in this area. Fingers crossed.

Bottom line strategy: The charts of VTR have been hurt. A low could be in the process this week but then we would want to see some fresh accumulation before being attracted to the long side.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | REITs | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Healthcare | Mad Money | Executive Interview | Coronavirus

More from Investing

Biden's Tax Policy Sucker Punches Stocks

James "Rev Shark" DePorre
Apr 22, 2021 4:17 PM EDT

The market is concerned that these taxes would trigger a rush to lock in gains before possibly higher rates went into effect.

Boston Scientific Makes an Important Upside Breakout

Bruce Kamich
Apr 22, 2021 3:25 PM EDT

Time to go long?

Jim Cramer: If the Capital Gains Taxman Cometh, Be Ready for Anything

Jim Cramer
Apr 22, 2021 3:10 PM EDT

Don't fear the taxman, view this one as an opportunity, not a penalty.

Take the Pedal Off the Metals?

Carley Garner
Apr 22, 2021 2:39 PM EDT

A deep dive into gold, silver and copper.

Cleveland-Cliffs Looks Ready to Resume Its Uptrend

Bruce Kamich
Apr 22, 2021 1:46 PM EDT

Here's how to play it.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:35 AM EDT BOB LANG

    Join Me for a Special Earth Day Webinar, Talking Volatility and VIX

    After the close Thursday join me for a free webina...
  • 04:17 PM EDT REAL MONEY

    Wednesday on Real Money Pro

    Get-rich quick schemes offer little more than pipe...
  • 11:09 AM EDT GARY BERMAN

    S&P Futures

    FIBOCALL: The S&P futures was off 1.5 %... ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login